Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Elastase inhibition as a potential approach to treating acute viral myocarditis

Dec. 16, 1998

Eisai launches new formulation of antiarrhythmic drug in Japan

Dec. 16, 1998

FDA grants expedited development status to Cordox as it begins phase III trials

Dec. 16, 1998

New prostanoid compound from Ono is a useful tool for studying cardiovascular system

Dec. 15, 1998

P&G submits NDA for antiarrhythmic drug azimilide

Dec. 14, 1998

Adenosine absorption inhibitors from Kyowa Hakko useful as antiinflammatories, cardioprotectants

Dec. 11, 1998

Carbostyril compounds useful for arteriosclerosis and thrombosis

Dec. 10, 1998

Competitive LPS antagonist E-5531 suppresses LPS-mediated effects in vitro and in vivo

Dec. 9, 1998

Pharmacyclics' photoangioplasty a hot topic at RSNA

Dec. 9, 1998

Electroporation catheter safely and effectively delivers heparin to arterial wall

Dec. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...